Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 449

1.

Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.

Sulkowski MS, Naggie S, Lalezari J, Fessel WJ, Mounzer K, Shuhart M, Luetkemeyer AF, Asmuth D, Gaggar A, Ni L, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Rodriguez-Torres M, Dieterich D; PHOTON-1 Investigators.

JAMA. 2014 Jul 23-30;312(4):353-61. doi: 10.1001/jama.2014.7734.

PMID:
25038354
[PubMed - in process]
2.

HIV-Hepatitis C Virus Co-infection in the era of Direct-Acting Antivirals.

Bichoupan K, Dieterich DT, Martel-Laferrière V.

Curr HIV/AIDS Rep. 2014 Jul 5. [Epub ahead of print]

PMID:
24996617
[PubMed - as supplied by publisher]
3.

Sofosbuvir for the treatment of chronic hepatitis C virus infection.

Temesgen Z, Talwani R, Rizza SA.

Drugs Today (Barc). 2014 Jun;50(6):421-34. doi: 10.1358/dot.2014.50.6.2141371.

PMID:
24983590
[PubMed - in process]
4.

Drug Interactions and Antiretroviral Drug Monitoring.

Foy M, Sperati CJ, Lucas GM, Estrella MM.

Curr HIV/AIDS Rep. 2014 Jun 22. [Epub ahead of print]

PMID:
24950731
[PubMed - as supplied by publisher]
5.

Hepatitis C in HIV-Infected Patients: Impact of Direct-Acting Antivirals.

Bichoupan K, Dieterich DT.

Drugs. 2014 Jun;74(9):951-61. doi: 10.1007/s40265-014-0232-6.

PMID:
24866024
[PubMed - in process]
6.

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives.

Degasperi E, Aghemo A.

Hepat Med. 2014 Apr 29;6:25-33. doi: 10.2147/HMER.S44375. eCollection 2014. Review.

PMID:
24822024
[PubMed]
Free PMC Article
7.

Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.

Mandorfer M, Payer BA, Niederecker A, Lang G, Aichelburg MC, Strassl R, Boesecke C, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T.

AIDS Patient Care STDS. 2014 May;28(5):221-7. doi: 10.1089/apc.2013.0359.

PMID:
24796757
[PubMed - indexed for MEDLINE]
8.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chêne G, Molina JM; ANRS 12 180 Reflate TB study group.

Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9. Erratum in: Lancet Infect Dis. 2014 Jun;14(6):448.

PMID:
24726095
[PubMed - indexed for MEDLINE]
9.

Acyclic nucleoside phosphonates: a study on cytochrome P450 gene expression.

Nekvindova J, Contreras JA, Juvan P, Fon Tacer K, Anzenbacher P, Zidek Z, Kopecna Zapletalova M, Rozman D, Anzenbacherova E.

Xenobiotica. 2014 Aug;44(8):708-15. doi: 10.3109/00498254.2014.895880. Epub 2014 Mar 5.

PMID:
24593268
[PubMed - in process]
10.

Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.

Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP.

Expert Rev Gastroenterol Hepatol. 2014 May;8(4):351-8. doi: 10.1586/17474124.2014.888949. Epub 2014 Mar 3.

PMID:
24580042
[PubMed - in process]
11.

Towards hepatitis C eradication from the HIV-infected population.

Barreiro P, Fernandez-Montero JV, de Mendoza C, Labarga P, Soriano V.

Antiviral Res. 2014 May;105:1-7. doi: 10.1016/j.antiviral.2014.02.004. Epub 2014 Feb 15.

PMID:
24534673
[PubMed - in process]
12.

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.

Hull M, Klein M, Shafran S, Tseng A, Giguère P, Côté P, Poliquin M, Cooper C.

Can J Infect Dis Med Microbiol. 2013 Winter;24(4):217-38. Erratum in: Can J Infect Dis Med Microbiol. 2014;24(1):63.

PMID:
24489565
[PubMed]
13.

RNAi and miRNA in viral infections and cancers.

Mollaie HR, Monavari SH, Arabzadeh SA, Shamsi-Shahrabadi M, Fazlalipour M, Afshar RM.

Asian Pac J Cancer Prev. 2013;14(12):7045-56.

PMID:
24460249
[PubMed - in process]
Free Article
14.

Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.

Kang W, Tong HI, Sun Y, Lu Y.

Expert Rev Gastroenterol Hepatol. 2014 Mar;8(3):247-66. doi: 10.1586/17474124.2014.876357. Epub 2014 Jan 22.

PMID:
24450362
[PubMed - in process]
15.

How to optimize current therapy of HCV genotype 1 infection with boceprevir.

Bourlière M, Adhoute X, Wendt A, Ansaldi C, Oules V, Castellani P.

Liver Int. 2014 Feb;34 Suppl 1:4-10. doi: 10.1111/liv.12390.

PMID:
24373071
[PubMed - in process]
16.

Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV.

Laufer NL, Rockstroh JK.

Expert Rev Anti Infect Ther. 2014 Feb;12(2):157-64. doi: 10.1586/14787210.2014.868774. Epub 2013 Dec 18.

PMID:
24350778
[PubMed - in process]
17.

Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection.

Karageorgopoulos DE, El-Sherif O, Bhagani S, Khoo SH.

Curr Opin Infect Dis. 2014 Feb;27(1):36-45. doi: 10.1097/QCO.0000000000000034. Review.

PMID:
24305043
[PubMed - indexed for MEDLINE]
18.

Two-way interaction study between ritonavir boosted danoprevir, a potent HCV protease inhibitor, and ketoconazole in healthy subjects.

Morcos PN, Chang L, Navarro M, Chung D, Smith PF, Brennan BJ, Tran JQ.

Int J Clin Pharmacol Ther. 2014 Feb;52(2):103-11. doi: 10.5414/CP201922.

PMID:
24290411
[PubMed - indexed for MEDLINE]
19.

Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014.

Chastain CA, Naggie S.

Curr HIV/AIDS Rep. 2013 Dec;10(4):408-19. doi: 10.1007/s11904-013-0182-8. Review.

PMID:
24272069
[PubMed - indexed for MEDLINE]
20.

Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups.

Hayes-Larson E, Grau LE, Khoshnood K, Barbour R, Khuat OT, Heimer R.

Harm Reduct J. 2013 Nov 22;10(1):33. doi: 10.1186/1477-7517-10-33.

PMID:
24268108
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk